Mineralys Therapeutics Inc (MLYS)

10:03 AM

Buy Rating on Mineralys Therapeutics: Promising Outcomes for Lorundrostat in Hypertension and Beyond - TipRanks

10:03 AM

09:32 AM

A Quick Look at Today's Ratings for Mineralys Therapeutics(MLYS.US), With a Forecast Between $26 to $45 - 富途牛牛

09:32 AM

09:07 AM

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q2 2025 Earnings Call Transcript - Insider Monkey

09:07 AM

09:03 AM

Positive Buy Rating for Mineralys Therapeutics, Inc. Driven by Promising Lorundrostat Outcomes and Strong Financial Position - TipRanks

09:03 AM

08:09 AM

Mineralys signals pre-NDA meeting for lorundrostat in Q4 2025 while expanding clinical programs into cardiorenal comorbidities - MSN

08:09 AM

12:23 PM

Mineralys Therapeutics Q2 2025: Unraveling Contradictions in Manufacturing, Trials, and Market Strategies - AInvest

12:23 PM

12:09 PM

Mineralys Therapeutics Reports Positive Q2 2025 Results - TipRanks

12:09 PM

Aug 12, 2025

Transcript : Mineralys Therapeutics, Inc., Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener

Aug 12, 2025

Aug 12, 2025

Mineralys Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat

Aug 12, 2025

Aug 12, 2025

Earnings call transcript: Mineralys Therapeutics beats Q2 2025 EPS forecast, stock rises - Investing.com Nigeria

Aug 12, 2025

Aug 12, 2025

Mineralys Therapeutics, Inc. SEC 10-Q Report - TradingView

Aug 12, 2025

Aug 12, 2025

Mineralys Therapeutics Q2 GAAP Loss Narrows - MarketScreener

Aug 12, 2025

Aug 12, 2025

Mineralys Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

Aug 12, 2025

Aug 12, 2025

Mineralys' Hypertension Drug Shows Promise in Multiple Studies, Heads Toward FDA Filing - Stock Titan

Aug 12, 2025

Aug 08, 2025

Mineralys Therapeutics to Announce Q2 Financial Results on August 12 - MSN

Aug 08, 2025

Aug 05, 2025

Mineralys Therapeutics CFO & Secretary Adam Levy Sells 36% Of Holding - simplywall.st

Aug 05, 2025

Aug 04, 2025

Mineralys Therapeutics to Announce Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 12, 2025 - The Manila Times

Aug 04, 2025

Aug 04, 2025

Momentum Screeners Rank Mineralys Therapeutics Inc. in Top 5 TodaySwing Trading Plan With Smart Signals in Review - beatles.ru

Aug 04, 2025

Aug 04, 2025

Support Zone Holds Steady for Mineralys Therapeutics Inc. After DipLow Capital High Return Stock Plans Reviewed - metal.it

Aug 04, 2025

Aug 04, 2025

Mineralys Therapeutics to Announce Second Quarter 2025 - GlobeNewswire

Aug 04, 2025

Aug 03, 2025

What drives Mineralys Therapeutics Inc. stock priceAchieve consistent profits with smart trading - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How many analysts rate Mineralys Therapeutics Inc. as a “Buy”Explosive trading growth - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are Mineralys Therapeutics Inc. company’s key revenue driversBuild a diversified portfolio for risk management - Jammu Links News

Aug 03, 2025

Aug 02, 2025

What catalysts could drive Mineralys Therapeutics Inc. stock higher in 2025Unlock exclusive trading tools and resources - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Mineralys Therapeutics Inc. Stock Analysis and ForecastAchieve breakthrough investment performance - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Is Mineralys Therapeutics Inc. stock overvalued or undervaluedBuild wealth steadily with smart stock selection - Jammu Links News

Aug 02, 2025

Aug 02, 2025

What is the dividend policy of Mineralys Therapeutics Inc. stockCapitalize on market trends with confidence - jammulinksnews.com

Aug 02, 2025

Aug 02, 2025

How volatile is Mineralys Therapeutics Inc. stock compared to the marketMaster the art of timing market moves - Jammu Links News

Aug 02, 2025

Aug 02, 2025

How strong is Mineralys Therapeutics Inc. company’s balance sheetCapitalize on fast-moving trading opportunities - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Is it the right time to buy Mineralys Therapeutics Inc. stockBuild a balanced portfolio for long-term success - Jammu Links News

Aug 02, 2025

Aug 01, 2025

CFO & Secretary Of Mineralys Therapeutics Sold 36% Of Their Shares - 富途牛牛

Aug 01, 2025

Jul 31, 2025

Treatment Resistant Hypertension Market Set to Transform at a CAGR of 5% with Increasing Diagnosis and Treatment of Resistant Patients along with Approval and Development of Newer Therapies During the Study Period (2020-2034) | DelveInsight - Yahoo Finance

Jul 31, 2025

Jul 31, 2025

Mineralys Therapeutics Insider Sold Shares Worth $1,077,477, According to a Recent SEC Filing - 富途牛牛

Jul 31, 2025

Jul 30, 2025

Mineralys Therapeutics CFO Adam Levy sells $1m+ in shares By Investing.com - Investing.com Australia

Jul 30, 2025

Jul 30, 2025

Mineralys Therapeutics CFO Adam Levy sells $1m+ in shares - Investing.com

Jul 30, 2025

Jul 30, 2025

Mineralys CFO Sells 12946 Shares at $14.04/Share on 2025-07-28 - AInvest

Jul 30, 2025

Jul 30, 2025

What analysts say about Mineralys Therapeutics Inc. stock outlookRisk Adjusted Technical Entry Plan Gains Followers - beatles.ru

Jul 30, 2025

Jul 30, 2025

Why Mineralys Therapeutics Inc. stock attracts strong analyst attentionNews Based Entry Opportunity Alerts Detected - beatles.ru

Jul 30, 2025

Jul 28, 2025

Will Mineralys Therapeutics Inc. stock split in the near futureTrend Analysis for Safer Trades Gains Popularity - metal.it

Jul 28, 2025

Jul 28, 2025

Aldosterone Synthase Inhibitors Market is evolving rapidly - openPR.com

Jul 28, 2025

Jul 28, 2025

Intrinsic Value of Mineralys Therapeutics Inc. Stock: Is It Undervalued or OvervaluedAccurate Technical Trend Reversal Picks Detected - metal.it

Jul 28, 2025

Jul 28, 2025

Is Mineralys Therapeutics Inc. a growth stock or a value stockExceptional market positioning - Jammu Links News

Jul 28, 2025

Jul 28, 2025

Why is Mineralys Therapeutics Inc. stock attracting strong analyst attentionOutstanding trading profits - Jammu Links News

Jul 28, 2025

Jul 27, 2025

What are the latest earnings results for Mineralys Therapeutics Inc.Get real-time updates on market trends - Jammu Links News

Jul 27, 2025

Jul 27, 2025

What are the technical indicators suggesting about Mineralys Therapeutics Inc.Unrivaled growth potential - Jammu Links News

Jul 27, 2025

Jul 27, 2025

What is Mineralys Therapeutics Inc. company’s growth strategyPowerful market insights - jammulinksnews.com

Jul 27, 2025